Clinical applications
Clinical applications
To illustrate the application of the Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines to the management of dogs and cats at risk of developing thrombosis the working group created a series of clinical cases that could be used to demonstrate how guideline recommendations could be applied.
The case studies provided are
- A dog with immune mediated haemolytic anaemia
- Aortic thrombosis in a dog with protein losing nephropathy
- A dog receiving antithrombotic drugs that now requires surgery
- A dog with sepsis
- A dog with hyperadrenocorticism and pancreatitis
- Initial presentation of a cat with cardiac disease
- Subsequent presentation of a cat with cardiac disease and ATE
This paper also includes information on the drug formulations available and indicative costs,as provided by contributors from the US, Canada, the UK, and Australia.
Sharp, C.R. et al. (2019) Clinical application of the American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines to small animal cases. Journal of Veterinary Emergency and Critical Care, 29 (2), pp. 121-131 [This article can be accessed via RCVS Knowledge Library membership, click here]
American College of Veterinary Emergency and Critical Care (ACVECC) consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines under five headings:
Domain 1 – Defining populations at risk
Domain 2 – Defining rational therapeutic usage
Domain 3 – Defining antithrombotic protocols
Domain 4 – Refining and monitoring antithrombotic therapies
Domain 5 – Discontinuation of anticoagulant therapy in small animals
Clinical applications
Online full-text available to Library members
A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.
Image copyright attribute:
Shane Maritch
Leave a Reply
Want to join the discussion?Feel free to contribute!